- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Roopa Industries Ltd is in the business of TPP and its allied productsBusiness Overview: RIL manufactures Bulk Drugs, Drug Intermediates, Nutraceuticals, and fine chemicals. It produces Active Pharmaceutical Ingredients such as Fluconazole, Sildenafil Citrate, Losartan Potassium and Triphenyl Phosphine (which goes into production of Cephalosporins, Statins etc.,) and Nutraceuticals such...
ROOPA INDUSTRIES LIMITED's Board of Directors has approved the notice for its 41st Annual General Meeting (AGM). The AGM is scheduled for September 30 and will be held virtually via video conferencing. Shareholders eligible to vote will be those on record as of the cut-off date, September 18. Remote e-voting...
Roopa Industries announced its financial results for the quarter ended 30 June 2026. Total income from operations was ₹3.33 Cr. The company reported a net profit of ₹0.33 Cr for the period, with earnings per share (basic and diluted) at ₹0.43. These unaudited results were reviewed by the Audit Committee...